| | | | | |
ANIK Anika Therapeutics Inc | $21,3900 | +0,61% | $294,82M | $89,33K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,4850 | +0,05% | $294,73M | $7,11K | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10,1200 | +0,80% | $294,68M | $14,28K | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $42,5100 | +1,02% | $294,53M | $19,11K | |
| $43,3300 | -0,60% | $294,35M | $9,63K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $9,9900 | -0,10% | $294,35M | $184,00 | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10,0800 | +0,00% | $294,33M | $818,00 | |
SLN Silence Therapeutics Plc American Depository Share | $13,1850 | -3,12% | $294,27M | $585,22K | |
MTNE CH4 Natural Solutions Corporation | $9,8950 | +0,05% | $293,88M | $3,40K | |
RXST RxSight, Inc. Common Stock | $6,0950 | -1,06% | $293,64M | $663,00K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10,6200 | -0,14% | $293,52M | $583,92K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10,0250 | +0,00% | $293,49M | $639,00 | |
CNXU Conexeu Sciences Inc. Common Stock | $9,3750 | +4,63% | $293,27M | $246,23K | |
| $10,6500 | +3,10% | $292,98M | $1,46M | |
JCE Nuveen Core Equity Alpha Fund | $16,9700 | +0,03% | $292,78M | $16,24K | |
